journal article·2018-10-03

Anticancer activity of metal nanoparticles and their peptide conjugates against human colon adenorectal carcinoma cells

Jamuna Bai Aswathanarayan, Ravishankar Rai Vittal, Umashankar Muddegowda

Publisher page

Abstract

In the present study, nanoparticles of gold, iron oxide and zinc oxide (ZnO) were studied for cytotoxicity in the colorectal cancer cell HT 29. The metallic nanoparticles in the range of <50 and <100 nm were screened for anticancer activity by MTT assay. The nanoparticles were tested at concentrations ranging from 0.5 to 50 µg/ml. Zinc oxide exhibited significant anti-cancer activity in comparison to other nanoparticles. It had an IC50 value of 17.12 µg/ml. The mechanism of action was studied by fluorescence microscopy with acridine orange, propidium iodide and DAPI staining techniques. The ROS production of ZnO nanoparticles was determined by DCFH-DA. The ZnO nanoparticles were conjugated with novel hydrophobic peptides and evaluated for anticancer activity. It was observed that the nanoparticles peptide complex showed better cytotoxicity than either peptide or nanoparticle alone. Thus, the ZnO nanoparticles tested in our study has anticancer activity against colon cancer cells. It can also be conjugated with peptides and used for targeting cancer cells with higher efficacy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Studies in Microbiology, University of Mysore, Mysore, India;

Department of Studies in Chemistry, Karnataka State Open University (KSOU), Mysore, India

Funding

University Grants Commission

References (30)

Show source-provided references
1. 10.3390/nano502100410.3390/nano5021004 ↗
2. 10.1517/17425247.2010.50256010.1517/17425247.2010.502560 ↗
3. 10.1016/j.jconrel.2015.05.00310.1016/j.jconrel.2015.05.003 ↗
4. 10.1016/j.bcp.2014.08.01510.1016/j.bcp.2014.08.015 ↗
5. 10.4103/0975-7406.7212710.4103/0975-7406.72127 ↗
6. 10.1007/978-1-62703-577-4_1410.1007/978-1-62703-577-4_14 ↗
7. 10.1186/s11671-016-1511-910.1186/s11671-016-1511-9 ↗
8. 10.1038/srep2307710.1038/srep23077 ↗
9. 10.12659/MSMBR.89332710.12659/MSMBR.893327 ↗
10. Abruzzo A, Zuccheri G, Belluti F, et al. Chitosan nanoparticles for lipophilic anticancer drug delivery: development, characterization and in vitro studies on HT29 cancer cells. Colloids Surf B Biointerfaces. 2016;145:362–372.10.1016/j.colsurfb.2016.05.023 ↗
11. 10.1016/j.cis.2011.04.00310.1016/j.cis.2011.04.003 ↗
12. 10.1016/j.nano.2014.07.00710.1016/j.nano.2014.07.007 ↗
13. 10.1016/j.biomaterials.2008.09.04410.1016/j.biomaterials.2008.09.044 ↗
14. Silva AC · Int J Nanomed · 2011 · 6 · 591
15. 10.3109/0265673100374574010.3109/02656731003745740 ↗
16. 10.1007/s11060-010-0389-010.1007/s11060-010-0389-0 ↗
17. 10.1007/s13204-014-0336-z10.1007/s13204-014-0336-z ↗
18. Rajeshkumar S. Anticancer activity of eco-friendly gold nanoparticles against lung and liver cancer cells. J Genet Eng Biotechnol. 2016;14:195–202.10.1016/j.jgeb.2016.05.007 ↗
19. 10.1158/1078-0432.CCR-04-248210.1158/1078-0432.CCR-04-2482 ↗
20. 10.1007/s12274-009-9089-510.1007/s12274-009-9089-5 ↗
21. 10.1016/j.nano.2010.10.00110.1016/j.nano.2010.10.001 ↗
22. Akhtar MJ · Int J Nanomedicine · 2012 · 7 · 845
23. Taccola L · Int J Nanomedicine · 2011 · 6 · 1129
24. 10.5772/6343710.5772/63437 ↗
25. 10.1155/2013/94291610.1155/2013/942916 ↗
26. 10.1016/j.cbi.2005.12.00910.1016/j.cbi.2005.12.009 ↗
27. 10.3389/fmicb.2013.0029410.3389/fmicb.2013.00294 ↗
28. Sharma H, Kumar K, Choudhary C, et al. Development and characterization of metal oxide nanoparticles for the delivery of anticancer drug. Artif Cells Nanomed Biotechnol. 2016;44:672–679.10.3109/21691401.2014.978980 ↗
29. Farkhani SM, Fard AA, Zakeri-Milani P, et al. Enhancing antitumor activity of silver nanoparticles by modification with cell-penetrating peptides. Artif Cells Nanomed Biotechnol. 2016;45:1029–1035.10.1080/21691401.2016.1200059 ↗
30. 10.1080/21691401.2017.129064310.1080/21691401.2017.1290643 ↗